UnitedHealth (UNH) Stock Forecast & Price Target
0 Followers
UNH Analyst Ratings
Strong Buy
14Buy3Hold0Sell
Based on 17 analysts giving stock ratings to UnitedHealth in the past 3 months
UNH Stock 12 Month Forecast
Average Price Target
MXN 9,092.56▲(18.42% Upside)Based on 17 Wall Street analysts offering 12 month price targets for UnitedHealth in the last 3 months. The average price target is MXN 9,092.56 with a high forecast of MXN 10,002.64 and a low forecast of MXN 7,572.62. The average price target represents a 18.42% change from the last price of MXN 7,678.00.
Past 12 Months12 Month ForecastJan2026Oct2026
HighMXN 10K
AverageMXN 9.09K
LowMXN 7.57K
Highest Price TargetHighestMXN 10,002.64Average Price TargetMXN 9,092.56Lowest Price TargetLowestMXN 7,572.62
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Lance Wilkes | Bernstein | MXN 9,418.68 | buy | 22.67%Upside | Reiterated | 11/04/26 | ||
| Stephen Baxter | Wells Fargo | MXN 9,908.45→MXN 9,173.79 | buy | 19.48%Upside | Reiterated | 10/27/26 | ||
| Erin Wright | Morgan Stanley | MXN 9,964.96→MXN 10,002.64 | buy | 30.28%Upside | Reiterated | 10/27/26 | ||
| Ann Hynes | Mizuho Securities | MXN 9,286.82→MXN 9,418.68 | buy | 22.67%Upside | Reiterated | 10/22/26 | ||
| Ben Hendrix | RBC Capital | MXN 9,004.26→MXN 9,381.00 | buy | 22.18%Upside | Assigned | 10/19/26 | ||
| Lisa Gill | J.P. Morgan | MXN 9,720.08→MXN 9,870.78 | buy | 28.56%Upside | Assigned | 10/16/26 | ||
| Whit Mayo | Leerink Partners | MXN 8,891.23 | buy | 15.80%Upside | Assigned | 10/15/26 | ||
| Ryan Langston | TD Cowen | MXN 7,572.62 | hold | -1.37%Downside | Reiterated | 10/15/26 | ||
| Parker Snure | Raymond James | MXN 8,947.75→MXN 8,476.81 | buy | 10.40%Upside | Reiterated | 10/15/26 | ||
| Andrew Mok CFA | Barclays | MXN 8,307.27→MXN 8,288.44 | buy | 7.95%Upside | Reiterated | 10/14/26 | ||
| Kevin Fischbeck | Bank of America Securities | MXN 9,644.73 | buy | 25.62%Upside | Reiterated | 10/14/26 | ||
| Jessica Tassan | Piper Sandler | MXN 9,456.35→MXN 9,494.03 | buy | 23.65%Upside | Reiterated | 10/14/26 | ||
| Michael Ha | Robert W. Baird | MXN 8,533.32→MXN 8,043.55 | hold | 4.76%Upside | Reiterated | 10/14/26 | ||
| Elizabeth Anderson CFA | Evercore ISI | MXN 9,041.93 | buy | 17.76%Upside | Reiterated | 10/13/26 | ||
| Scott Fidel | Goldman Sachs | MXN 9,230.31→MXN 9,531.70 | buy | 24.14%Upside | Reiterated | 10/13/26 |
| Rating | Follow | Article | |||
|---|---|---|---|---|---|
| Lance WilkesBernstein | BuyReiteratedMXN 9,418.68 | 11/04/26 | 22.67%Upside | ||
| Stephen BaxterWells Fargo | BuyReiteratedMXN 9,908.45→MXN 9,173.79 | 10/27/26 | 19.48%Upside | ||
| Erin WrightMorgan Stanley | BuyReiteratedMXN 9,964.96→MXN 10,002.64 | 10/27/26 | 30.28%Upside | ||
| Ann HynesMizuho Securities | BuyReiteratedMXN 9,286.82→MXN 9,418.68 | 10/22/26 | 22.67%Upside | ||
| Ben HendrixRBC Capital | BuyAssignedMXN 9,004.26→MXN 9,381.00 | 10/19/26 | 22.18%Upside | ||
| Lisa GillJ.P. Morgan | BuyAssignedMXN 9,720.08→MXN 9,870.78 | 10/16/26 | 28.56%Upside | ||
| Whit MayoLeerink Partners | BuyAssignedMXN 8,891.23 | 10/15/26 | 15.80%Upside | ||
| Ryan LangstonTD Cowen | HoldReiteratedMXN 7,572.62 | 10/15/26 | -1.37%Downside | ||
| Parker SnureRaymond James | BuyReiteratedMXN 8,947.75→MXN 8,476.81 | 10/15/26 | 10.40%Upside | ||
| Andrew Mok CFABarclays | BuyReiteratedMXN 8,307.27→MXN 8,288.44 | 10/14/26 | 7.95%Upside | ||
| Kevin FischbeckBank of America Securities | BuyReiteratedMXN 9,644.73 | 10/14/26 | 25.62%Upside | ||
| Jessica TassanPiper Sandler | BuyReiteratedMXN 9,456.35→MXN 9,494.03 | 10/14/26 | 23.65%Upside | ||
| Michael HaRobert W. Baird | HoldReiteratedMXN 8,533.32→MXN 8,043.55 | 10/14/26 | 4.76%Upside | ||
| Elizabeth Anderson CFAEvercore ISI | BuyReiteratedMXN 9,041.93 | 10/13/26 | 17.76%Upside | ||
| Scott FidelGoldman Sachs | BuyReiteratedMXN 9,230.31→MXN 9,531.70 | 10/13/26 | 24.14%Upside |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering UnitedHealth
3 Months
Success Rate34/49 ratings generated profit
69%
Average Return
+6.36%
Copying A.J. Rice's trades and holding each position for 3 Months would result in 69.39% of your transactions generating a profit, with an average return of +6.36% per trade.
1 Year
Success Rate39/47 ratings generated profit
83%
Average Return
+20.51%
Copying Scott Fidel's trades and holding each position for 1 Year would result in 82.98% of your transactions generating a profit, with an average return of +20.51% per trade.
2 Years
Success Rate44/49 ratings generated profit
90%
Average Return
+42.39%
Copying A.J. Rice's trades and holding each position for 2 Years would result in 89.80% of your transactions generating a profit, with an average return of +42.39% per trade.
UNH Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 34 | 28 | 27 | 28 | 27 |
| Hold | 5 | 6 | 6 | 6 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 39 | 34 | 33 | 34 | 31 |
In the current month, UNH has received 27 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. UNH average Analyst price target in the past 3 months is 9,092.56.
UNH Financial Forecast
HighMXN 49.35
ConsensusMXN 42.89
LowMXN 40.50
UNH Earnings Forecast
Next quarter’s earnings estimate for UNH is MXN 42.89 with a range of MXN 40.50 to MXN 49.35. The previous quarter’s EPS was MXN 88.35. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighMXN 2.17T
ConsensusMXN 2.11T
LowMXN 2.06T
UNH Sales Forecast
Next quarter’s sales forecast for UNH is MXN 2.11T with a range of MXN 2.06T to MXN 2.17T. The previous quarter’s sales results were MXN 2.12T. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
UNH Stock Forecast FAQ
What is MX:UNH’s average 12-month price target, according to analysts?
Based on analyst ratings, UnitedHealth’s 12-month average price target is Mex$9,092.56.
What is MX:UNH’s upside potential, based on the analysts’ average price target?
UnitedHealth has 18.42% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is UnitedHealth a Buy, Sell or Hold?
UnitedHealth has a consensus rating of Strong Buy, which is based on 14 buy ratings, 3 hold ratings and 0 sell ratings.
What is UnitedHealth’s share price target?
The average share price target for UnitedHealth is Mex$9,092.56. This is based on 17 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is Mex$10,002.64, and the lowest forecast is Mex$7,572.62. The average share price target represents a 18.42% increase from the current price of Mex$7,678.
What do analysts say about UnitedHealth?
UnitedHealth’s analyst rating consensus is a Strong Buy. This is based on the ratings of 17 Wall Street analysts.
How can I buy shares of UnitedHealth?
To buy shares of MX:UNH, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
